Home ROVI announces an agreement with Biogaran for the marketing of its enoxaparin biosimilar in France

ROVI announces an agreement with Biogaran for the marketing of its enoxaparin biosimilar in France

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
ROVI announces an agreement with Biogaran for the marketing of its enoxaparin biosimilar in France
https://www.rovi.es/sites/default/files/uk%20Press%20Release%20Biogaran__0.pdf
Year: 
2018